Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11787793 Heterocyclic compounds as immunomodulators

Patent 11787793 was granted and assigned to Incyte on October, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Wenqing Yao

Liangxing Wu

Jingwei Li

Date of Patent

October 17, 2023

Patent Application Number

17672351

Date Filed

February 15, 2022

Patent Citations

US Patent 7691870 Benzimidazole carboxamides as raf kinase inhibitors

US Patent 6867200 (Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors

US Patent 7320989 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists

US Patent 7417065 Immunosuppressant compounds and compositions

US Patent 7488802 Antibodies against PD-1

US Patent 7491245 Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof

US Patent 11339149 Heterocyclic compounds as immunomodulators

US Patent 11401279 Pyrido[3,2-d]pyrimidine compounds as immunomodulators

...

Patent Citations Received

US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor

0

US Patent 11866435 Heterocyclic compounds as immunomodulators

0

Patent Primary Examiner

Samantha L Shterengarts

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11787793 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.